The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

DHS' Temporary Commissioner Shireen Gandhi wrote a letter Friday to the federal Centers for Medicare and Medicaid Services ...

Critics fear that personal data might be used to monitor immigrants and political foes, and to spread false tales of fraud.

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

A new rule issued by the Centers for Medicare and Medicaid Services will strip DACA recipients of eligibility for coverage ...

The Centers for Medicare & Medicaid Services awarded the Department of Public Health and Social Services $39 million for the ...

Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...

Minnesota’s Department of Human Services is moving to terminate a Medicaid-funded housing assistance program after federal ...

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach for many obese Americans.

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

Some obese Americans on Medicare and Medicaid could get access to expensive weight loss drugs under a five-year experiment ...